Multiple	O
proteins	O
interact	O
with	O
the	O
nuclear	B-DNA
inhibitory	I-DNA
protein	I-DNA
repressor	I-DNA
element	I-DNA
in	O
the	O
human	B-DNA
interleukin-3	I-DNA
promoter	I-DNA
.	O

T	O
cell	O
expression	O
of	O
interleukin	B-protein
3	I-protein
(	O
IL-3	B-protein
)	O
is	O
directed	O
by	O
positive	B-DNA
and	I-DNA
negative	I-DNA
cis-acting	I-DNA
DNA	I-DNA
elements	I-DNA
clustered	O
within	O
300	O
base	O
pairs	O
of	O
the	O
transcriptional	B-DNA
start	I-DNA
site	I-DNA
.	O

A	O
strong	O
repressor	B-protein
element	I-protein
,	O
termed	O
nuclear	B-protein
inhibitory	I-protein
protein	I-protein
(	O
NIP	B-protein
)	O
,	O
was	O
previously	O
mapped	O
to	O
a	O
segment	O
of	O
the	O
IL-3	B-DNA
promoter	I-DNA
between	O
nucleotides	B-DNA
-271	I-DNA
and	I-DNA
-250	I-DNA
.	O

Functional	O
characterization	O
of	O
this	O
element	O
demonstrates	O
that	O
it	O
can	O
mediate	O
repression	O
when	O
linked	O
in	O
cis	O
to	O
a	O
heterologous	B-DNA
promoter	I-DNA
.	O

DNA	O
binding	O
experiments	O
were	O
carried	O
out	O
to	O
characterize	O
the	O
repressor	O
activity	O
.	O

Using	O
varying	O
conditions	O
,	O
three	O
distinct	O
complexes	O
were	O
shown	O
to	O
interact	O
specifically	O
with	O
the	O
NIP	B-DNA
region	I-DNA
,	O
although	O
only	O
one	O
correlates	O
with	O
repressor	O
activity	O
.	O

Complex	B-protein
1	I-protein
results	O
from	O
binding	O
of	O
a	O
ubiquitous	O
polypeptide	O
that	O
recognizes	O
the	O
3	B-DNA
'	I-DNA
portion	I-DNA
of	O
this	O
sequence	O
and	O
is	O
not	O
required	O
for	O
repression	O
.	O

Complex	B-protein
2	I-protein
corresponds	O
to	O
binding	O
of	O
transcription	B-protein
factor	I-protein
(	O
upstream	B-protein
stimulatory	I-protein
factor	I-protein
)	O
to	O
an	O
E-box	B-DNA
motif	I-DNA
in	O
the	O
5	B-DNA
'	I-DNA
portion	I-DNA
of	O
the	O
NIP	B-DNA
region	I-DNA
.	O

DNA	O
binding	O
specificity	O
of	O
complex	O
3	O
overlaps	O
with	O
that	O
of	O
upstream	B-protein
stimulatory	I-protein
factor	I-protein
but	O
is	O
clearly	O
distinct	O
.	O

To	O
determine	O
which	O
of	O
the	O
latter	O
two	O
complexes	O
represents	O
NIP	B-protein
activity	O
,	O
we	O
incorporated	O
small	O
alterations	O
into	O
the	O
NIP	B-DNA
site	I-DNA
of	O
an	O
IL-3	B-DNA
promoter-linked	I-DNA
reporter	I-DNA
construct	I-DNA
and	O
examined	O
their	O
effects	O
on	O
NIP	B-protein
-mediated	O
repression	O
.	O

Functional	O
specificity	O
for	O
repression	O
matches	O
the	O
DNA	O
binding	O
specificity	O
of	O
complex	B-protein
3	I-protein
;	O
both	O
repressor	O
activity	O
and	O
complex	B-protein
3	I-protein
binding	O
require	O
the	O
consensus	B-DNA
sequence	I-DNA
CTCACNTNC	O
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

41	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
13	NULL
,	NULL
pp	NULL
.	NULL

24572-24579	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Multiple	NULL
Proteins	NULL
Interact	NULL
with	NULL
the	NULL
Nuclear	NULL
Inhibitory	NULL
Protein	NULL
Repressor	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
Interleukin-3	NULL
Promoter*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
5	NULL
,	NULL
1995	NULL
)	NULL
Kurt	NULL
Engeland	NULL
#	NULL
§	NULL
,	NULL
Nancy	NULL
C.	NULL
Andrews	NULL
#	NULL
(	NULL
|	NULL
,	NULL
and	NULL
Bernard	NULL
Mathey-Prevot	NULL
?	NULL

**	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
the	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
and	NULL
(	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
T	NULL
cell	NULL
expression	NULL
of	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
is	NULL
directed	NULL
by	NULL
positive	NULL
and	NULL
negative	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
clustered	NULL
within	NULL
300	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

A	NULL
strong	NULL
repressor	NULL
element	NULL
,	NULL
termed	NULL
nuclear	NULL
inhibitory	NULL
protein	NULL
(	NULL
NIP	NULL
)	NULL
,	NULL
was	NULL
previously	NULL
mapped	NULL
to	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
between	NULL
nucleotides	NULL
-271	NULL
and	NULL
-250	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
this	NULL
element	NULL
demonstrates	NULL
that	NULL
it	NULL
can	NULL
mediate	NULL
repression	NULL
when	NULL
linked	NULL
in	NULL
cis	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

DNA	NULL
binding	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
characterize	NULL
the	NULL
repressor	NULL
activity	NULL
.	NULL

Using	NULL
varying	NULL
conditions	NULL
,	NULL
three	NULL
distinct	NULL
complexes	NULL
were	NULL
shown	NULL
to	NULL
interact	NULL
specifically	NULL
with	NULL
the	NULL
NIP	NULL
region	NULL
,	NULL
although	NULL
only	NULL
one	NULL
correlates	NULL
with	NULL
repressor	NULL
activity	NULL
.	NULL

Complex	NULL
1	NULL
results	NULL
from	NULL
binding	NULL
of	NULL
a	NULL
ubiquitous	NULL
polypeptide	NULL
that	NULL
recognizes	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
this	NULL
sequence	NULL
and	NULL
is	NULL
not	NULL
required	NULL
for	NULL
repression	NULL
.	NULL

Complex	NULL
2	NULL
corresponds	NULL
to	NULL
binding	NULL
of	NULL
transcription	NULL
factor	NULL
(	NULL
upstream	NULL
stimulatory	NULL
fac-tor	NULL
)	NULL
to	NULL
an	NULL
E-box	NULL
motif	NULL
in	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
NIP	NULL
region	NULL
.	NULL

DNA	NULL
binding	NULL
specificity	NULL
of	NULL
complex	NULL
3	NULL
overlaps	NULL
with	NULL
that	NULL
of	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
but	NULL
is	NULL
clearly	NULL
distinct	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
of	NULL
the	NULL
latter	NULL
two	NULL
complexes	NULL
represents	NULL
NIP	NULL
activity	NULL
,	NULL
we	NULL
incorporated	NULL
small	NULL
alterations	NULL
into	NULL
the	NULL
NIP	NULL
site	NULL
of	NULL
an	NULL
IL-3	NULL
promoter-linked	NULL
reporter	NULL
construct	NULL
and	NULL
examined	NULL
their	NULL
effects	NULL
on	NULL
NIP-mediated	NULL
repression	NULL
.	NULL

Functional	NULL
specificity	NULL
for	NULL
repression	NULL
matches	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
complex	NULL
3	NULL
;	NULL
both	NULL
repressor	NULL
activity	NULL
and	NULL
complex	NULL
3	NULL
binding	NULL
require	NULL
the	NULL
consensus	NULL
sequence	NULL
CTCACNTNC	NULL
.	NULL

Human	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
``	NULL
is	NULL
a	NULL
potent	NULL
growth	NULL
factor	NULL
,	NULL
which	NULL
supports	NULL
early	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
and	NULL
potentiates	NULL
lineage-specific	NULL
effects	NULL
of	NULL
later	NULL
acting	NULL
growth	NULL
factors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

IL-3	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
3-6	NULL
)	NULL
and	NULL
is	NULL
regulated	NULL
primarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

cis-acting	NULL
promoter	NULL
elements	NULL
governing	NULL
tissue-specific	NULL
and	NULL
ac-tivation-dependent	NULL
expression	NULL
are	NULL
found	NULL
within	NULL
300	NULL
base	NULL
pairs	NULL
*	NULL
This	NULL
work	NULL
has	NULL
been	NULL
funded	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
RO1	NULL
DK41758	NULL
(	NULL
to	NULL
B.	NULL
M.-P.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Current	NULL
address	NULL
:	NULL
Institut	NULL
fiir	NULL
Molekularbiologie	NULL
und	NULL
Tumorfors-chung	NULL
,	NULL
Philipps-Universitat	NULL
Marburg	NULL
,	NULL
D-35037	NULL
Marburg	NULL
,	NULL
Germany	NULL
.	NULL

|	NULL
Assistant	NULL
Investigator	NULL
of	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

**	NULL
Partially	NULL
supported	NULL
by	NULL
funds	NULL
from	NULL
the	NULL
Genetics	NULL
Institute	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dana-Farber	NULL
Cancer	NULL
Inst	NULL
.	NULL

,	NULL
D1640A	NULL
,	NULL
44	NULL
Binney	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-632-3535	NULL
;	NULL
Fax	NULL
:	NULL
617-632-2085	NULL
;	NULL
E-mail	NULL
,	NULL
bernard_mathey-prevot	NULL
@	NULL
macmailgw.dfei	NULL
.	NULL

harvard.edu	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
NIP	NULL
,	NULL
nuclear	NULL
inhibitory	NULL
protein	NULL
;	NULL
nt	NULL
,	NULL
nucleotide	NULL
(	NULL
s	NULL
)	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

(	NULL
bp	NULL
)	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
8-13	NULL
)	NULL
.	NULL

Promoter	NULL
deletion	NULL
experiments	NULL
have	NULL
identified	NULL
two	NULL
activating	NULL
sites	NULL
referred	NULL
to	NULL
as	NULL
ACT-1	NULL
(	NULL
NFIL-3	NULL
)	NULL
and	NULL
AP-1/Elf-1	NULL
(	NULL
8-10	NULL
,	NULL
12	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
is	NULL
a	NULL
powerful	NULL
repressor	NULL
site	NULL
,	NULL
which	NULL
binds	NULL
an	NULL
activity	NULL
termed	NULL
nuclear	NULL
inhibitory	NULL
protein	NULL
(	NULL
NIP	NULL
)	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Functional	NULL
experiments	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
localized	NULL
the	NULL
NIP	NULL
element	NULL
between	NULL
nucleotides	NULL
-271	NULL
and	NULL
-250	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
(	NULL
9	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
showed	NULL
that	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
AP-1	NULL
and	NULL
EIf-1	NULL
sites	NULL
,	NULL
the	NULL
NIP	NULL
element	NULL
blocks	NULL
activation	NULL
mediated	NULL
by	NULL
the	NULL
downstream	NULL
ACT-1	NULL
and	NULL
CBF	NULL
sites	NULL
,	NULL
thus	NULL
silencing	NULL
IL-3	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
the	NULL
NIP	NULL
repressor	NULL
has	NULL
remained	NULL
elusive	NULL
subsequent	NULL
to	NULL
this	NULL
initial	NULL
characterization	NULL
.	NULL

Studies	NULL
with	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
promoter	NULL
identified	NULL
a	NULL
repressor	NULL
site	NULL
,	NULL
NRE-A	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
zinc	NULL
finger	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-3	NULL
genes	NULL
have	NULL
common	NULL
characteristics	NULL
and	NULL
function	NULL
exclusively	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
NIP	NULL
and	NULL
NRE-A	NULL
sites	NULL
might	NULL
be	NULL
related	NULL
.	NULL

A	NULL
second	NULL
possible	NULL
identity	NULL
for	NULL
NIP	NULL
was	NULL
suggested	NULL
by	NULL
sequence	NULL
analysis	NULL
,	NULL
which	NULL
revealed	NULL
that	NULL
the	NULL
NIP	NULL
site	NULL
contains	NULL
a	NULL
consensus	NULL
E-box	NULL
sequence	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
that	NULL
might	NULL
be	NULL
recognized	NULL
by	NULL
a	NULL
helix-loop-helix	NULL
transcription	NULL
factor	NULL
.	NULL

To	NULL
better	NULL
define	NULL
how	NULL
NIP	NULL
interacts	NULL
with	NULL
the	NULL
IL-3	NULL
promoter	NULL
and	NULL
to	NULL
characterize	NULL
the	NULL
protein	NULL
mediating	NULL
repressor	NULL
activity	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
nucleotide	NULL
requirements	NULL
for	NULL
NIP	NULL
function	NULL
.	NULL

In	NULL
parallel	NULL
we	NULL
have	NULL
investigated	NULL
three	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
repressor	NULL
site	NULL
to	NULL
determine	NULL
which	NULL
correlates	NULL
with	NULL
the	NULL
repressor	NULL
activity	NULL
of	NULL
NIP	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
show	NULL
that	NULL
NIP	NULL
and	NULL
NRE-A	NULL
are	NULL
distinct	NULL
elements	NULL
and	NULL
that	NULL
the	NULL
repressor	NULL
protein	NULL
NIP	NULL
does	NULL
not	NULL
belong	NULL
to	NULL
the	NULL
E-box	NULL
binding	NULL
class	NULL
of	NULL
transcriptional	NULL
regulators	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Lines-The	NULL
gibbon	NULL
T	NULL
cell	NULL
line	NULL
MLA	NULL
144	NULL
(	NULL
17	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
(	NULL
50	NULL
units/ml	NULL
penicillin	NULL
;	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
}	NULL
.	NULL

The	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus-transformed	NULL
Raji	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
K562	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
a	NULL
murine	NULL
Abelson-murine	NULL
leukemia	NULL
virus-transformed	NULL
pre-B	NULL
cell	NULL
line	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

Mouse	NULL
erythroleukemia	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
2.5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
7.5	NULL
%	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Oligonucleotides	NULL
and	NULL
IL-3	NULL
Promoter	NULL
Constructs-Sequences	NULL
of	NULL
one	NULL
strand	NULL
of	NULL
the	NULL
double-stranded	NULL
oligonucleotides	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
are	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

All	NULL
IL-3	NULL
promoter	NULL
segments	NULL
are	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
consisting	NULL
of	NULL
a	NULL
modified	NULL
human	NULL
IL-3	NULL
gene	NULL
(	NULL
IL3®	NULL
)	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
gene	NULL
-173/IL3	NULL
``	NULL
has	NULL
been	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
(	NULL
NIP	NULL
)	NULL
-173/IL3*	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
spanning	NULL
nt	NULL
-267	NULL
to	NULL
-244	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
was	NULL
ligated	NULL
upstream	NULL
of	NULL
-173/1L3	NULL
``	NULL
.	NULL

For	NULL
-267/IL3	NULL
``	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
was	NULL
used	NULL
to	NULL
amplify	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
between	NULL
nt	NULL
-267	NULL
and	NULL
-1	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
used	NULL
in	NULL
the	NULL
reaction	NULL
incorporated	NULL
a	NULL
HindIII	NULL
restriction	NULL
site	NULL
for	NULL
cloning	NULL
purposes	NULL
.	NULL

The	NULL
PCR	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Smal	NULL
(	NULL
position	NULL
-61	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
)	NULL
and	NULL
sub	NULL
24572	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
cloned	NULL
into	NULL
the	NULL
unique	NULL
HindIII	NULL
and	NULL
Smeal	NULL
sites	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
fragment	NULL
in	NULL
-173/IL3*®	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
an	NULL
L3	NULL
``	NULL
reporter	NULL
gene	NULL
linked	NULL
to	NULL
an	NULL
IL-3	NULL
promoter	NULL
extending	NULL
to	NULL
nt	NULL
-267	NULL
.	NULL

Upstream	NULL
primers	NULL
that	NULL
incorporated	NULL
mutations	NULL
in	NULL
the	NULL
NIP	NULL
site	NULL
listed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
used	NULL
on	NULL
the	NULL
-267/IL3*	NULL
DNA	NULL
template	NULL
to	NULL
generate	NULL
(	NULL
by	NULL
PCR	NULL
)	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
M5	NULL
,	NULL
M6	NULL
,	NULL
M7	NULL
,	NULL
M8	NULL
,	NULL
M9	NULL
,	NULL
and	NULL
M10	NULL
IL3*	NULL
reporter	NULL
gene	NULL
mutants	NULL
.	NULL

Sequence	NULL
integrity	NULL
for	NULL
all	NULL
new	NULL
constructs	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
Smal	NULL
sites	NULL
.	NULL

All	NULL
oligonucleotides	NULL
(	NULL
for	NULL
PCR	NULL
and	NULL
EMSA	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Oligonucleotide	NULL
Core	NULL
Facility	NULL
at	NULL
the	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
.	NULL

Granulocyte-Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
Promoter	NULL
Constructs-For	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
from	NULL
nt	NULL
-215	NULL
to	NULL
-17	NULL
was	NULL
subcloned	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
presumed	NULL
start	NULL
site	NULL
in	NULL
the	NULL
IL3*	NULL
reporter	NULL
gene	NULL
at	NULL
a	NULL
BanII	NULL
site	NULL
.	NULL

For	NULL
(	NULL
NIP	NULL
)	NULL
-215	NULL
%	NULL
/IL3*	NULL
,	NULL
the	NULL
same	NULL
double-stranded	NULL
NIP	NULL
oligonucleotide	NULL
present	NULL
in	NULL
(	NULL
NIP	NULL
)	NULL
-173/IL3*	NULL
was	NULL
subcloned	NULL
upstream	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
area	NULL
of	NULL
interest	NULL
was	NULL
sequenced	NULL
to	NULL
confirm	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
construct	NULL
.	NULL

DNA	NULL
Electroporation-4	NULL
X	NULL
10	NULL
``	NULL
MLA	NULL
144	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
3.5	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
lacking	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

For	NULL
each	NULL
electropora-tion	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
suspension	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
split	NULL
into	NULL
four	NULL
aliquots	NULL
and	NULL
transferred	NULL
to	NULL
disposable	NULL
cuvettes	NULL
for	NULL
electroporation	NULL
in	NULL
ProGene-tor	NULL
II	NULL
(	NULL
Hoefer	NULL
Scientific	NULL
Instruments	NULL
)	NULL
set	NULL
at	NULL
275	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
a	NULL
total	NULL
of	NULL
50	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
complete	NULL
with	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

After	NULL
36-40	NULL
h	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
9	NULL
h	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
(	NULL
10	NULL
ng/ml	NULL
final	NULL
concentration	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
RNase	NULL
Protection	NULL
Assay-Total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
genes	NULL
was	NULL
analyzed	NULL
by	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
is	NULL
complementary	NULL
to	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
IL-3	NULL
reporter	NULL
gene	NULL
,	NULL
including	NULL
an	NULL
insertion	NULL
of	NULL
a	NULL
12-bp	NULL
XhoI	NULL
linker	NULL
at	NULL
a	NULL
Hincll	NULL
site	NULL
.	NULL

After	NULL
ribonuclease	NULL
A	NULL
and	NULL
T1	NULL
digestion	NULL
,	NULL
transcripts	NULL
corresponding	NULL
to	NULL
the	NULL
IL-3	NULL
reporter	NULL
genes	NULL
protect	NULL
a	NULL
226-nt	NULL
fragment	NULL
,	NULL
whereas	NULL
endogenous	NULL
MLA	NULL
144	NULL
IL-3	NULL
transcripts	NULL
(	NULL
lacking	NULL
the	NULL
12-bp	NULL
linker	NULL
)	NULL
give	NULL
rise	NULL
to	NULL
two	NULL
protected	NULL
fragments	NULL
of	NULL
151	NULL
and	NULL
63	NULL
nt	NULL
,	NULL
respectively	NULL
(	NULL
9	NULL
)	NULL
.	NULL

EMSAs-Crude	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
by	NULL
the	NULL
Dignam	NULL
procedure	NULL
(	NULL
19	NULL
)	NULL
or	NULL
a	NULL
modified	NULL
procedure	NULL
by	NULL
Andrews	NULL
and	NULL
Faller	NULL
(	NULL
20	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
extracts	NULL
(	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
Jurkat	NULL
and	NULL
MLA	NULL
144	NULL
cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng/ml	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
and	NULL
0.5	NULL
um	NULL
ionomycin	NULL
for	NULL
6	NULL
h	NULL
prior	NULL
to	NULL
nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

Protease	NULL
inhibitors	NULL
(	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
and	NULL
Sigma	NULL
)	NULL
were	NULL
included	NULL
in	NULL
all	NULL
extract	NULL
preparation	NULL
steps	NULL
:	NULL
0.2	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
A	NULL
,	NULL
0.1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
0.4	NULL
ug/ml	NULL
aprotinin	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
mouse	NULL
myotube	NULL
cells	NULL
(	NULL
C2DM	NULL
)	NULL
were	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
S.	NULL
Skapek	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
.	NULL

Purified	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
(	NULL
USF	NULL
)	NULL
from	NULL
HeLa	NULL
cells	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
D.	NULL
Fisher	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
duplexes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
by	NULL
filling	NULL
in	NULL
sticky	NULL
ends	NULL
with	NULL
Klenow	NULL
polymerase	NULL
.	NULL

Labeled	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
by	NULL
electrophoresis	NULL
through	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Bands	NULL
were	NULL
excised	NULL
,	NULL
and	NULL
oligonucleotides	NULL
were	NULL
eluted	NULL
,	NULL
precipitated	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
H	NULL
,	NULL
O	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
proteins	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
approximately	NULL
100	NULL
fmol/15	NULL
ul	NULL
assay	NULL
.	NULL

Two	NULL
different	NULL
buffers	NULL
were	NULL
used	NULL
for	NULL
the	NULL
binding	NULL
reaction	NULL
:	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mm	NULL
Hepes/NaOH	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mM	NULL
potassium	NULL
glutamate	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
pg/15	NULL
ul	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
)	NULL
and	NULL
buffer	NULL
B	NULL
(	NULL
10	NULL
mm	NULL
Tris/HCl	NULL
]	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
4	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
20	NULL
pM	NULL
ZnSQ	NULL
,	NULL
,	NULL
and	NULL
1	NULL
ug/15	NULL
pl	NULL
poly	NULL
(	NULL
dA	NULL
}	NULL
poly	NULL
(	NULL
dT	NULL
)	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
about	NULL
5	NULL
pg	NULL
of	NULL
total	NULL
protein/assay	NULL
with	NULL
radiolabeled	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
20	NULL
min	NULL
at	NULL
22	NULL
°C	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
excess	NULL
unlabeled	NULL
oligonucleotides	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
at	NULL
40	NULL
ng/15	NULL
ul	NULL
,	NULL
a	NULL
50-100-fold	NULL
excess	NULL
)	NULL
,	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
adding	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
unrelated	NULL
oligonucleotide	NULL
(	NULL
non-specific	NULL
)	NULL
used	NULL
in	NULL
competition	NULL
was	NULL
AGCTTACGTCTGTGGATC	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
at	NULL
22°C	NULL
through	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
X	NULL
TBE	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
on	NULL
Whatman	NULL
3MM	NULL
paper	NULL
and	NULL
used	NULL
to	NULL
expose	NULL
Kodak	NULL
x-ray	NULL
film	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Immunologic	NULL
Assays	NULL
of	NULL
Basic	NULL
Helix-loop-helix	NULL
Proteins-Anti-E12	NULL
antiserum	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
C.	NULL
Murre	NULL
(	NULL
UCSD	NULL
)	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
preparations	NULL
recognizing	NULL
E2-2	NULL
,	NULL
E2-2/E12	NULL
,	NULL
and	NULL
E12/E47	NULL
were	NULL
provided	NULL
by	NULL
PharMingen	NULL
Inc.	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
IgG	NULL
recognizing	NULL
a	NULL
20-amino	NULL
acid	NULL
C-terminal	NULL
peptide	NULL
of	NULL
USF	NULL
and	NULL
a	NULL
sample	NULL
of	NULL
that	NULL
peptide	NULL
(	NULL
at	NULL
0.2	NULL
mg/m	NULL
!	NULL
)	NULL

were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-USF	NULL
antibody	NULL
(	NULL
0.05	NULL
ug	NULL
)	NULL
was	NULL
incubated	NULL
at	NULL
22°C	NULL
in	NULL
15	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
plus	NULL
nuclear	NULL
extract	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Antibody	NULL
specificity	NULL
24573	NULL
a	NULL
x	NULL
«	NULL
-g	NULL
Bo	NULL
p	NULL
H	NULL
=	NULL
Ro	NULL
gz	NULL
a8	NULL
<	NULL
4	NULL
g	NULL
Z	NULL
4	NULL
§	NULL
68	NULL
qs	NULL
C	NULL
:	NULL
-	NULL
k	NULL
IL-3	NULL
Promoter	NULL
300	NULL
s	NULL
100	NULL
a	NULL
b	NULL
@	NULL
§	NULL
{	NULL
HI—4—l	NULL
-173	NULL
/	NULL
ILs	NULL
&	NULL
Z	NULL
(	NULL
b	NULL
)	NULL
Mé-LM—H	NULL
’	NULL
(	NULL
NIP	NULL
)	NULL
-173	NULL
/	NULL
11.3	NULL
%	NULL
>	NULL
-	NULL
W	NULL
#	NULL
(	NULL
a	NULL
)	NULL
«	NULL
215	NULL
A7	NULL
I	NULL
1	NULL
(	NULL
c	NULL
)	NULL
En	NULL
]	NULL
-215GMIL3S®	NULL
¥	NULL
ae	NULL
0	NULL
2	NULL
(	NULL
0	NULL
)	NULL
_	NULL
@	NULL
p	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
”	NULL
ﬂ	NULL
”	NULL
?	NULL

3x	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
NIP	NULL
repressor	NULL
site	NULL
functions	NULL
in	NULL
a	NULL
different	NULL
position	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
and	NULL
in	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

A	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
wild-type	NULL
IL-3	NULL
promoter	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
fop	NULL
.	NULL

Reporter	NULL
genes	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
were	NULL
transfected	NULL
into	NULL
MLA	NULL
144	NULL
cells	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
monitored	NULL
by	NULL
RNase	NULL
protection	NULL
using	NULL
a	NULL
modified	NULL
IL-3	NULL
first	NULL
exon	NULL
probe	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
a	NULL
226-nt	NULL
protected	NULL
fragment	NULL
resulting	NULL
from	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
prominent	NULL
151-nt	NULL
fragment	NULL
(	NULL
in	NULL
the	NULL
lower	NULL
part	NULL
of	NULL
the	NULL
gels	NULL
)	NULL
results	NULL
from	NULL
protection	NULL
of	NULL
the	NULL
probe	NULL
by	NULL
gibbon	NULL
endogenous	NULL
IL-3	NULL
mRNA	NULL
and	NULL
serves	NULL
as	NULL
internal	NULL
control	NULL
for	NULL
loading	NULL
(	NULL
9	NULL
)	NULL
.	NULL

A	NULL
,	NULL
constructs	NULL
a	NULL
and	NULL
b	NULL
contain	NULL
a	NULL
truncated	NULL
portion	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
-173	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
known	NULL
regulatory	NULL
sites	NULL
ACT-1	NULL
(	NULL
10	NULL
)	NULL
,	NULL
CBF	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
DB1	NULL
(	NULL
13	NULL
)	NULL
and	NULL
other	NULL
potential	NULL
sites	NULL
(	NULL
CK1	NULL
,	NULL
CK2	NULL
,	NULL
and	NULL
CACC	NULL
)	NULL
(	NULL
9	NULL
,	NULL
11	NULL
)	NULL
.	NULL

In	NULL
construct	NULL
b	NULL
,	NULL
the	NULL
NIP	NULL
segment	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
-173	NULL
promoter	NULL
,	NULL
thus	NULL
altering	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

B	NULL
,	NULL
in	NULL
constructs	NULL
c	NULL
and	NULL
d	NULL
,	NULL
the	NULL
IL-3	NULL
promoter	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
GM-CSF	NULL
promoter	NULL
fragment	NULL
(	NULL
-215	NULL
)	NULL
known	NULL
to	NULL
direct	NULL
regulated	NULL
expression	NULL
of	NULL
GM-CSF	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Construct	NULL
d	NULL
contains	NULL
the	NULL
NIP	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
-215	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Lane	NULL
a	NULL
,	NULL
-173/IL3*	NULL
;	NULL
lane	NULL
b	NULL
,	NULL
(	NULL
NIP	NULL
)	NULL
-173/IL3®	NULL
;	NULL
lane	NULL
c	NULL
,	NULL
-215GM/AL3*	NULL
;	NULL
lene	NULL
d	NULL
,	NULL
(	NULL
NIP	NULL
)	NULL
-215GM/AIL3*	NULL
.	NULL

was	NULL
confirmed	NULL
by	NULL
preincubation	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
20-amino	NULL
acid	NULL
C-terminal	NULL
USF	NULL
peptide	NULL
for	NULL
5	NULL
h	NULL
at	NULL
22°C	NULL
before	NULL
proceeding	NULL
with	NULL
the	NULL
binding	NULL
reaction	NULL
as	NULL
described	NULL
above	NULL
.	NULL

RESULTS	NULL
The	NULL
NIP	NULL
Element	NULL
Is	NULL
a	NULL
General	NULL
Repressor	NULL
Site-Deletion	NULL
analysis	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
revealed	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
silencing	NULL
element	NULL
,	NULL
NIP	NULL
,	NULL
between	NULL
bp	NULL
-267	NULL
and	NULL
-244	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
region	NULL
exhibits	NULL
a	NULL
repressor	NULL
function	NULL
outside	NULL
of	NULL
its	NULL
usual	NULL
context	NULL
,	NULL
it	NULL
was	NULL
placed	NULL
upstream	NULL
of	NULL
a	NULL
truncated	NULL
version	NULL
of	NULL
the	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
measured	NULL
by	NULL
RNase	NULL
protection	NULL
after	NULL
transient	NULL
transfection	NULL
into	NULL
the	NULL
gibbon	NULL
T	NULL
cell	NULL
line	NULL
MLA	NULL
144	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Expression	NULL
directed	NULL
by	NULL
the	NULL
truncated	NULL
-173	NULL
IL-3	NULL
promoter	NULL
(	NULL
-173/IL-3*	NULL
reporter	NULL
gene	NULL
)	NULL
was	NULL
completely	NULL
silenced	NULL
when	NULL
the	NULL
NIP	NULL
element	NULL
was	NULL
placed	NULL
just	NULL
upstream	NULL
of	NULL
it	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
IL-3	NULL
promoter	NULL
results	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
was	NULL
drasti-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24574	NULL
+270	NULL
~241	NULL
|	NULL
E-box	NULL
|	NULL
NIP	NULL
gaTccrCcTesREETECTGCCATGCTTCCCATCTag	NULL
NIP-5	NULL
!	NULL

NIP-3	NULL
'	NULL
agetCTGCCATGCTTCCCATgate	NULL
NIP-A	NULL
gaTccrcreAee¥ScTtc	NULL
--	NULL
--	NULL
GCTrcccATCTag	NULL
Mutant	NULL
M1	NULL
3	NULL
M2	NULL
gaTCCTCTgAQCTébTGCt	NULL
ag	NULL
M3	NULL
agctTCCTCﬁéCQf'GCTGCCATGCgatc	NULL
M4	NULL
agctTCTi—	NULL
LeereereccaTeerrecc	NULL
MS	NULL
gaTCCTCTgfﬁQC	NULL
’	NULL
i	NULL
‘	NULL
éCTGCtag	NULL
MG	NULL
c	NULL
M7	NULL
MBS	NULL
Mg	NULL
M10	NULL
«	NULL
E2	NULL
USF	NULL
CTAGGCEACGTGACCGate	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Sequence	NULL
of	NULL
wild-type	NULL
and	NULL
NIP	NULL
oligonucleotides	NULL
and	NULL
other	NULL
probes	NULL
used	NULL
in	NULL
EMSA	NULL
.	NULL

Only	NULL
the	NULL
top	NULL
strand	NULL
is	NULL
indicated	NULL
.	NULL

Wild-type	NULL
nucleotides	NULL
are	NULL
shown	NULL
in	NULL
capifal	NULL
Zeffers	NULL
,	NULL
mutations	NULL
in	NULL
boldface	NULL
.	NULL

Nucleotides	NULL
added	NULL
for	NULL
the	NULL
purpose	NULL
of	NULL
labeling	NULL
duplexes	NULL
using	NULL
Klenow	NULL
polymerase	NULL
are	NULL
shown	NULL
in	NULL
lowercase	NULL
.	NULL

Numbering	NULL
of	NULL
the	NULL
nucleotides	NULL
is	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Sequences	NULL
used	NULL
for	NULL
non-NIP	NULL
oligonucleotides	NULL
were	NULL
obtained	NULL
from	NULL
published	NULL
reports	NULL
:	NULL
«	NULL
E2	NULL
(	NULL
21	NULL
)	NULL
,	NULL
USF	NULL
site	NULL
in	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
region	NULL
corresponding	NULL
to	NULL
the	NULL
E-box	NULL
in	NULL
the	NULL
various	NULL
oligonucleotides	NULL
is	NULL
shaded	NULL
.	NULL

cally	NULL
reduced	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
when	NULL
the	NULL
NIP	NULL
element	NULL
was	NULL
placed	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
-215	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
c	NULL
and	NULL
d	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
NIP	NULL
site	NULL
can	NULL
function	NULL
as	NULL
a	NULL
silencer	NULL
element	NULL
in	NULL
a	NULL
heterologous	NULL
position	NULL
and	NULL
in	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

The	NULL
NIP	NULL
Site	NULL
interacts	NULL
with	NULL
Three	NULL
DNA-binding	NULL
Com-plexes-To	NULL
characterize	NULL
the	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
the	NULL
silencing	NULL
function	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
,	NULL
in	NULL
vitro	NULL
binding	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
region	NULL
between	NULL
-270	NULL
and	NULL
-241	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
an	NULL
EMSA	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
(	NULL
9	NULL
)	NULL
,	NULL
a	NULL
dominant	NULL
protein-DNA	NULL
complex	NULL
(	NULL
complex	NULL
1	NULL
)	NULL
was	NULL
detected	NULL
with	NULL
this	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Complex	NULL
1	NULL
is	NULL
specific	NULL
,	NULL
since	NULL
it	NULL
is	NULL
competed	NULL
by	NULL
excess	NULL
unlabeled	NULL
NIP	NULL
probe	NULL
and	NULL
not	NULL
by	NULL
excess	NULL
nonspecific	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

NIP-3	NULL
'	NULL
,	NULL
an	NULL
oligonucleotide	NULL
consisting	NULL
of	NULL
the	NULL
3	NULL
'	NULL
half	NULL
of	NULL
the	NULL
NIP	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
also	NULL
competed	NULL
complex	NULL
1	NULL
as	NULL
well	NULL
as	NULL
the	NULL
faster	NULL
migrating	NULL
bands	NULL
,	NULL
which	NULL
represent	NULL
degradation	NULL
products	NULL
of	NULL
complex	NULL
1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
fainter	NULL
complex	NULL
(	NULL
complex	NULL
2	NULL
)	NULL
forms	NULL
over	NULL
the	NULL
NIP	NULL
probe	NULL
.	NULL

Because	NULL
of	NULL
its	NULL
relatively	NULL
weak	NULL
binding	NULL
over	NULL
the	NULL
NIP	NULL
probe	NULL
,	NULL
complex	NULL
2	NULL
had	NULL
not	NULL
been	NULL
recognized	NULL
in	NULL
past	NULL
experiments	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Complex	NULL
2	NULL
binding	NULL
was	NULL
competed	NULL
by	NULL
excess	NULL
NIP	NULL
and	NULL
NIP-5	NULL
oligonucleotides	NULL
but	NULL
not	NULL
by	NULL
NIP-3	NULL
'	NULL
oligonucleotides	NULL
.	NULL

Last	NULL
,	NULL
there	NULL
was	NULL
a	NULL
slower	NULL
migrating	NULL
doublet	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
,	NULL
which	NULL
was	NULL
competed	NULL
by	NULL
NIP	NULL
but	NULL
not	NULL
by	NULL
NIP-5	NULL
'	NULL
or	NULL
NIP-3	NULL
'	NULL
oligonucleotides	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
this	NULL
doublet	NULL
was	NULL
not	NULL
pursued	NULL
since	NULL
its	NULL
detection	NULL
failed	NULL
to	NULL
correlate	NULL
with	NULL
repressor	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
formation	NULL
of	NULL
complexes	NULL
1	NULL
and	NULL
2	NULL
over	NULL
the	NULL
NIP	NULL
region	NULL
,	NULL
NIP-3	NULL
'	NULL
and	NULL
NIP-5	NULL
'	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
were	NULL
used	NULL
in	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
NIP-3	NULL
'	NULL
probe	NULL
specifically	NULL
bound	NULL
Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
complex	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
while	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
failed	NULL
to	NULL
do	NULL
so	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
NIP-5	NULL
'	NULL
bound	NULL
complex	NULL
2	NULL
.	NULL

Complex	NULL
2	NULL
is	NULL
specific	NULL
and	NULL
often	NULL
gives	NULL
rise	NULL
to	NULL
two	NULL
bands	NULL
,	NULL
one	NULL
major	NULL
band	NULL
and	NULL
a	NULL
slightly	NULL
faster	NULL
migrating	NULL
minor	NULL
band	NULL
.	NULL

The	NULL
two	NULL
bands	NULL
exhibit	NULL
identical	NULL
DNA	NULL
binding	NULL
specificity	NULL
in	NULL
EMSA	NULL
competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
maximize	NULL
detection	NULL
of	NULL
all	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
NIP	NULL
region	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
EMSAs	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
different	NULL
conditions	NULL
.	NULL

There	NULL
was	NULL
a	NULL
striking	NULL
difference	NULL
in	NULL
the	NULL
pattern	NULL
of	NULL
complexes	NULL
detected	NULL
when	NULL
poly	NULL
(	NULL
dA	NULL
)	NULL
poly	NULL
(	NULL
dT	NULL
)	NULL
was	NULL
used	NULL
as	NULL
nonspecific	NULL
carrier	NULL
DNA	NULL
in	NULL
place	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
an	NULL
additional	NULL
complex	NULL
(	NULL
complex	NULL
3	NULL
)	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
NIP	NULL
sequence	NULL
,	NULL
which	NULL
migrated	NULL
differently	NULL
from	NULL
complex	NULL
2	NULL
described	NULL
above	NULL
.	NULL

The	NULL
assignment	NULL
of	NULL
the	NULL
slower	NULL
migrating	NULL
band	NULL
as	NULL
complex	NULL
2	NULL
is	NULL
based	NULL
on	NULL
competition	NULL
experiments	NULL
using	NULL
a	NULL
variety	NULL
of	NULL
mutated	NULL
probes	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
8	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
band	NULL
in	NULL
Fig	NULL
.	NULL

3D	NULL
is	NULL
not	NULL
consistently	NULL
seen	NULL
in	NULL
our	NULL
different	NULL
nuclear	NULL
extracts	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
and	NULL
it	NULL
can	NULL
not	NULL
be	NULL
fully	NULL
competed	NULL
by	NULL
excess	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

Thus	NULL
,	NULL
three	NULL
distinct	NULL
,	NULL
specific	NULL
complexes	NULL
(	NULL
complexes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
)	NULL
are	NULL
reproducibly	NULL
detected	NULL
over	NULL
the	NULL
NIP	NULL
site	NULL
.	NULL

Binding	NULL
of	NULL
Complex	NULL
1	NULL
Is	NULL
Not	NULL
Necessary	NULL
for	NULL
Repression-The	NULL
most	NULL
prominent	NULL
complex	NULL
detected	NULL
with	NULL
the	NULL
NIP	NULL
probe	NULL
is	NULL
complex	NULL
1	NULL
.	NULL

To	NULL
examine	NULL
further	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
and	NULL
function	NULL
of	NULL
complex	NULL
1	NULL
,	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
was	NULL
prepared	NULL
in	NULL
which	NULL
four	NULL
bp	NULL
were	NULL
deleted	NULL
from	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
NIP	NULL
sequence	NULL
(	NULL
mutant	NULL
NIP-A	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
this	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
complex	NULL
1	NULL
binding	NULL
when	NULL
added	NULL
in	NULL
excess	NULL
and	NULL
failed	NULL
to	NULL
bind	NULL
complex	NULL
1	NULL
when	NULL
radiolabeled	NULL
and	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Binding	NULL
of	NULL
complex	NULL
2	NULL
to	NULL
NIP-A	NULL
was	NULL
unaffected	NULL
,	NULL
but	NULL
detection	NULL
required	NULL
a	NULL
much	NULL
longer	NULL
exposure	NULL
than	NULL
that	NULL
shown	NULL
for	NULL
this	NULL
experiment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
NIP-A	NULL
mutation	NULL
was	NULL
incorporated	NULL
into	NULL
the	NULL
-267/IL3*	NULL
reporter	NULL
construct	NULL
to	NULL
determine	NULL
whether	NULL
loss	NULL
of	NULL
complex	NULL
1	NULL
binding	NULL
correlated	NULL
with	NULL
a	NULL
change	NULL
in	NULL
repressor	NULL
activity	NULL
at	NULL
the	NULL
NIP	NULL
site	NULL
.	NULL

Its	NULL
activity	NULL
was	NULL
compared	NULL
with	NULL
-267/IL3*	NULL
(	NULL
wild-type	NULL
)	NULL
,	NULL
which	NULL
shows	NULL
repression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
a	NULL
construct	NULL
in	NULL
which	NULL
the	NULL
NIP	NULL
site	NULL
has	NULL
been	NULL
deleted	NULL
,	NULL
-250/IL3*	NULL
(	NULL
NIP	NULL
minus	NULL
)	NULL
,	NULL
which	NULL
shows	NULL
no	NULL
repression	NULL
.	NULL

As	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
4-bp	NULL
NIP-A	NULL
deletion	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
repression	NULL
function	NULL
.	NULL

Thus	NULL
,	NULL
complex	NULL
1	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
NIP	NULL
activity	NULL
,	NULL
and	NULL
its	NULL
binding	NULL
is	NULL
not	NULL
required	NULL
for	NULL
repression	NULL
to	NULL
take	NULL
place	NULL
.	NULL

Complex	NULL
2	NULL
Is	NULL
an	NULL
E-box	NULL
Complex	NULL
Immunologically	NULL
Related	NULL
to	NULL
USF-To	NULL
characterize	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
exhibited	NULL
by	NULL
complex	NULL
2	NULL
,	NULL
several	NULL
mutated	NULL
oligonucleotides	NULL
(	NULL
listed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
were	NULL
used	NULL
to	NULL
compete	NULL
binding	NULL
of	NULL
complex	NULL
2	NULL
to	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
demonstrates	NULL
that	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
E-box	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
is	NULL
essential	NULL
for	NULL
complex	NULL
2	NULL
binding	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
«	NULL
E2	NULL
site	NULL
(	NULL
21	NULL
)	NULL
,	NULL
which	NULL
has	NULL
only	NULL
the	NULL
E-box	NULL
consensus	NULL
sequence	NULL
in	NULL
common	NULL
with	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
,	NULL
completely	NULL
competes	NULL
binding	NULL
of	NULL
complex	NULL
2	NULL
.	NULL

A	NULL
compilation	NULL
of	NULL
the	NULL
results	NULL
observed	NULL
with	NULL
the	NULL
several	NULL
mutants	NULL
reveals	NULL
that	NULL
only	NULL
nucleotides	NULL
forming	NULL
the	NULL
E-box	NULL
consensus	NULL
,	NULL
i.e	NULL
.	NULL

CACNTG	NULL
,	NULL
are	NULL
necessary	NULL
.	NULL

Nucleotides	NULL
flanking	NULL
the	NULL
E-box	NULL
core	NULL
sequence	NULL
do	NULL
not	NULL
influence	NULL
binding	NULL
of	NULL
complex	NULL
2	NULL
in	NULL
vitro	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
second	NULL
of	NULL
the	NULL
two	NULL
cytidines	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
E-box	NULL
can	NULL
be	NULL
mutated	NULL
without	NULL
affecting	NULL
binding	NULL
of	NULL
complex	NULL
2	NULL
(	NULL
mutant	NULL
M6	NULL
)	NULL
.	NULL

Since	NULL
complex	NULL
2	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
all	NULL
cells	NULL
tested	NULL
and	NULL
requires	NULL
the	NULL
E-box	NULL
consensus	NULL
for	NULL
binding	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
complex	NULL
2	NULL
forms	NULL
from	NULL
binding	NULL
of	NULL
known	NULL
ubiquitous	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Antisera	NULL
raised	NULL
against	NULL
proteins	NULL
belonging	NULL
to	NULL
the	NULL
E2-2	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
failed	NULL
to	NULL
interfere	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
2	NULL
on	NULL
the	NULL
NIP-5	NULL
'	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
formation	NULL
of	NULL
complex	NULL
2	NULL
on	NULL
the	NULL
NIP-5	NULL
probe	NULL
was	NULL
blocked	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
antiserum	NULL
recognizing	NULL
the	NULL
20	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
USF	NULL
(	NULL
22	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

This	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
24575	NULL
A	NULL
B	NULL
C	NULL
D	NULL
£s	NULL
:	NULL
&	NULL
83°	NULL
3	NULL
$	NULL
,8	NULL
s	NULL
v	NULL
#	NULL
&	NULL
&	NULL
»	NULL
#	NULL
&	NULL
w	NULL
$	NULL
&	NULL
»	NULL
#	NULL
$	NULL
&	NULL
C2P	NULL
Ca	NULL
»	NULL
Seem	NULL
C2p	NULL
»	NULL
-	NULL
CBD	NULL
tou	NULL
B	NULL
--	NULL
ams	NULL
1	NULL
i	NULL
.	NULL

4	NULL
L	NULL
4	NULL
[	NULL
'	NULL
P	NULL
&	NULL
._____..j	NULL
NIP	NULL
Probe	NULL
NIP-3°	NULL
Probe	NULL
NIP-5	NULL
'	NULL
Probe	NULL
NIP-5	NULL
'	NULL
Probe	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

The	NULL
NIP	NULL
site	NULL
binds	NULL
three	NULL
distinct	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
(	NULL
panels	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
and	NULL
from	NULL
stimulated	NULL
MLA	NULL
144	NULL
cells	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
were	NULL
tested	NULL
in	NULL
EMSA	NULL
with	NULL
the	NULL
probes	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

Two	NULL
different	NULL
unstimulated	NULL
MLA	NULL
144	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Buffer	NULL
A	NULL
was	NULL
used	NULL
for	NULL
panels	NULL
A-C	NULL
,	NULL
and	NULL
buffer	NULL
B	NULL
was	NULL
used	NULL
for	NULL
panel	NULL
D.	NULL
All	NULL
probes	NULL
are	NULL
listed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Competitors	NULL
are	NULL
listed	NULL
above	NULL
each	NULL
Zane	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CZ	NULL
,	NULL
complex	NULL
1	NULL
;	NULL
C2	NULL
,	NULL
complex	NULL
2	NULL
;	NULL
C3	NULL
,	NULL
complex	NULL
8	NULL
.	NULL

&	NULL
RS	NULL
$	NULL
A	NULL
05°	NULL
B	NULL
$	NULL
90	NULL
6	NULL
‘	NULL
s	NULL
.	NULL

“	NULL
$	NULL
09	NULL
o	NULL
&	NULL
&	NULL
``	NULL
c	NULL
)	NULL
<	NULL
qu	NULL
o	NULL
r	NULL
{	NULL
2	NULL
‘	NULL
0	NULL
Competitors	NULL
:	NULL
¥	NULL
#	NULL
9	NULL
J	NULL
``	NULL
&	NULL
&	NULL
TS	NULL
&	NULL
>	NULL
~~~	NULL
|C	NULL
a	NULL
m	NULL
<	NULL
in	NULL
comes	NULL
:	NULL
«	NULL
ame	NULL
L_	NULL
NIP	NULL
Probe	NULL
NIP-A	NULL
Probe	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Complex	NULL
1	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
repression	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
an	NULL
EMSA	NULL
with	NULL
probes	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
gels	NULL
(	NULL
NIP	NULL
probe	NULL
and	NULL
mutant	NULL
NIP-A	NULL
probe	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
or	NULL
absence	NULL
(	NULL
No	NULL
)	NULL
and	NULL
the	NULL
type	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
are	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
extracts	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
or	NULL
extracts	NULL
from	NULL
MLA	NULL
144	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
T-cell	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
functional	NULL
consequence	NULL
of	NULL
the	NULL
4-bp	NULL
deletion	NULL
(	NULL
NIP-A	NULL
)	NULL
engineered	NULL
in	NULL
the	NULL
NIP	NULL
site	NULL
was	NULL
tested	NULL
in	NULL
MLA	NULL
144	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
IL-3	NULL
reporter	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
mediated	NULL
by	NULL
a	NULL
wild-type	NULL
IL-3	NULL
promoter	NULL
fragment	NULL
containing	NULL
the	NULL
NIP	NULL
site	NULL
(	NULL
-267/IL3*	NULL
)	NULL
and	NULL
by	NULL
the	NULL
same	NULL
fragment	NULL
containing	NULL
the	NULL
NIP-A	NULL
mutation	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
obtained	NULL
with	NULL
a	NULL
promoter	NULL
fragment	NULL
lacking	NULL
a	NULL
full	NULL
NIP	NULL
site	NULL
(	NULL
-250/IL3*®	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
this	NULL
latter	NULL
construct	NULL
is	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
-173/IL3*	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
protected	NULL
fragment	NULL
corresponding	NULL
to	NULL
the	NULL
reporter	NULL
gene	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
.	NULL

As	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
prominent	NULL
151-nt	NULL
fragment	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
gel	NULL
(	NULL
resulting	NULL
from	NULL
protection	NULL
by	NULL
endogenous	NULL
IL-3	NULL
mRNA	NULL
)	NULL
indicates	NULL
equal	NULL
loading	NULL
for	NULL
RNA	NULL
.	NULL

interaction	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
,	NULL
since	NULL
preincubation	NULL
of	NULL
the	NULL
antiserum	NULL
with	NULL
excess	NULL
peptide	NULL
against	NULL
which	NULL
it	NULL
was	NULL
raised	NULL
largely	NULL
restores	NULL
binding	NULL
of	NULL
complex	NULL
2	NULL
with	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
E-box	NULL
in	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
differs	NULL
from	NULL
the	NULL
previously	NULL
described	NULL
USF	NULL
consensus	NULL
sequence	NULL
(	NULL
22	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
bona	NULL
fide	NULL
USF	NULL
binding	NULL
site	NULL
(	NULL
from	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
)	NULL
to	NULL
confirm	NULL
our	NULL
initial	NULL
observa-tion	NULL
.	NULL

Using	NULL
the	NULL
USF	NULL
probe	NULL
under	NULL
identical	NULL
conditions	NULL
,	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
complex	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
can	NULL
be	NULL
detected	NULL
.	NULL

However	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
USF	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24576	NULL
$	NULL
9	NULL
C	NULL
&	NULL
Competitors	NULL
:	NULL
$	NULL
”	NULL
£235	NULL
¢m¢g¢hx¥ﬁ¢h~§é	NULL
°°	NULL
if	NULL
}	NULL
$	NULL
Complex	NULL
2	NULL
-	NULL
»	NULL
'	NULL
wat	NULL
==	NULL
was	NULL
ws	NULL
wes	NULL
.	NULL

wus	NULL
«	NULL
e	NULL
h	NULL
NIP-5	NULL
'	NULL
Probe	NULL
Complex	NULL
2	NULL
Binding	NULL
Consensus	NULL
:	NULL
NNCACNTGN	NULL
E-box	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Binding	NULL
specificity	NULL
of	NULL
complex	NULL
2	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
E-box	NULL
consensus	NULL
.	NULL

Nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
MLA	NULL
144	NULL
cells	NULL
was	NULL
used	NULL
in	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
buffer	NULL
A	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
various	NULL
competitors	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

These	NULL
conditions	NULL
preclude	NULL
detection	NULL
of	NULL
complex	NULL
3	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
competitors	NULL
used	NULL
are	NULL
given	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
deduced	NULL
binding	NULL
consensus	NULL
for	NULL
complex	NULL
2	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

probe	NULL
is	NULL
about	NULL
2	NULL
orders	NULL
of	NULL
magnitude	NULL
higher	NULL
than	NULL
it	NULL
is	NULL
for	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
.	NULL

Anti-USF	NULL
antiserum	NULL
interferes	NULL
with	NULL
binding	NULL
of	NULL
this	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
faint	NULL
supershift	NULL
is	NULL
apparent	NULL
for	NULL
this	NULL
probe	NULL
.	NULL

While	NULL
a	NULL
similar	NULL
supershift	NULL
is	NULL
not	NULL
readily	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
detection	NULL
of	NULL
such	NULL
a	NULL
supershift	NULL
requires	NULL
a	NULL
stronger	NULL
signal	NULL
for	NULL
complex	NULL
2	NULL
than	NULL
what	NULL
is	NULL
generally	NULL
observed	NULL
with	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
.	NULL

Alternatively	NULL
,	NULL
complex	NULL
2	NULL
may	NULL
only	NULL
be	NULL
related	NULL
to	NULL
USF	NULL
and	NULL
react	NULL
less	NULL
strongly	NULL
with	NULL
the	NULL
antiserum	NULL
.	NULL

To	NULL
confirm	NULL
our	NULL
observation	NULL
that	NULL
complex	NULL
2	NULL
is	NULL
USF	NULL
or	NULL
USF-related	NULL
,	NULL
purified	NULL
USF	NULL
from	NULL
Hela	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
NIP-5	NULL
'	NULL
and	NULL
USF	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

A	NULL
single	NULL
complex	NULL
with	NULL
identical	NULL
mobility	NULL
is	NULL
detected	NULL
with	NULL
both	NULL
probes	NULL
.	NULL

Again	NULL
,	NULL
purified	NULL
USF	NULL
binds	NULL
with	NULL
much	NULL
higher	NULL
affinity	NULL
to	NULL
the	NULL
viral	NULL
USF	NULL
site	NULL
than	NULL
it	NULL
does	NULL
to	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
.	NULL

Competition	NULL
experiments	NULL
using	NULL
USF	NULL
,	NULL
NIP-5	NULL
'	NULL
,	NULL
and	NULL
unrelated	NULL
oligonucleotides	NULL
confirmed	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
bindings	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
suggest	NULL
that	NULL
the	NULL
protein	NULL
component	NULL
of	NULL
complex	NULL
2	NULL
and	NULL
USF	NULL
are	NULL
the	NULL
same	NULL
or	NULL
highly	NULL
related	NULL
polypeptides	NULL
.	NULL

Repression	NULL
by	NULL
NIP	NULL
Does	NULL
Not	NULL
Require	NULL
an	NULL
Intact	NULL
E-box-As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
complex	NULL
3	NULL
also	NULL
forms	NULL
on	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
binding	NULL
of	NULL
either	NULL
complex	NULL
2	NULL
or	NULL
complex	NULL
3	NULL
correlated	NULL
with	NULL
repressor	NULL
function	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
detailed	NULL
muta-tional	NULL
analysis	NULL
.	NULL

Nucleotides	NULL
in	NULL
and	NULL
around	NULL
the	NULL
E-box	NULL
consensus	NULL
sequence	NULL
were	NULL
altered	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-267/IL,3*	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
these	NULL
mutations	NULL
on	NULL
reporter	NULL
gene	NULL
expression	NULL
was	NULL
assayed	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
the	NULL
mutations	NULL
interfered	NULL
with	NULL
repression	NULL
and	NULL
restored	NULL
reporter	NULL
gene	NULL
expression	NULL
to	NULL
a	NULL
level	NULL
comparable	NULL
with	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
-173	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
compare	NULL
lanes	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
M5	NULL
,	NULL
M7	NULL
,	NULL
M9	NULL
,	NULL
and	NULL
M10	NULL
with	NULL
lane	NULL
NIP	NULL
Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
minus	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutations	NULL
present	NULL
in	NULL
the	NULL
M6	NULL
and	NULL
M8	NULL
constructs	NULL
do	NULL
not	NULL
abrogate	NULL
repression	NULL
.	NULL

These	NULL
observations	NULL
,	NULL
together	NULL
with	NULL
results	NULL
obtained	NULL
from	NULL
three	NULL
additional	NULL
mutations	NULL
in	NULL
the	NULL
area	NULL
of	NULL
the	NULL
E-box	NULL
sequence	NULL
,	NULL
define	NULL
the	NULL
functional	NULL
consensus	NULL
for	NULL
NIP	NULL
repression	NULL
to	NULL
be	NULL
CTCACNTNC	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
consensus	NULL
indicates	NULL
that	NULL
complex	NULL
2/USF	NULL
can	NULL
not	NULL
represent	NULL
the	NULL
repressor	NULL
,	NULL
since	NULL
the	NULL
invariant	NULL
G	NULL
in	NULL
the	NULL
E-box	NULL
can	NULL
be	NULL
mutated	NULL
to	NULL
a	NULL
T	NULL
(	NULL
mutant	NULL
M8	NULL
)	NULL
without	NULL
affecting	NULL
repression	NULL
,	NULL
even	NULL
though	NULL
it	NULL
abrogates	NULL
binding	NULL
of	NULL
this	NULL
factor	NULL
in	NULL
competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
M8	NULL
)	NULL
.	NULL

Complex	NULL
3	NULL
Is	NULL
the	NULL
NIP	NULL
Repressor-Having	NULL
excluded	NULL
complex	NULL
2/USF	NULL
as	NULL
the	NULL
repressor	NULL
,	NULL
we	NULL
turned	NULL
our	NULL
attention	NULL
to	NULL
complex	NULL
3	NULL
.	NULL

The	NULL
NIP-5	NULL
'	NULL
oligonucleotide	NULL
duplex	NULL
and	NULL
four	NULL
informative	NULL
mutant	NULL
probes	NULL
were	NULL
used	NULL
in	NULL
EMSA	NULL
to	NULL
identify	NULL
a	NULL
protein	NULL
complex	NULL
that	NULL
showed	NULL
a	NULL
binding	NULL
pattern	NULL
matching	NULL
the	NULL
NIP	NULL
functional	NULL
consensus	NULL
.	NULL

The	NULL
NIP-5	NULL
'	NULL
wild-type	NULL
probe	NULL
as	NULL
well	NULL
as	NULL
mutant	NULL
M6	NULL
and	NULL
MBS	NULL
probes	NULL
should	NULL
bind	NULL
the	NULL
repressor	NULL
complex	NULL
,	NULL
while	NULL
the	NULL
mutant	NULL
M1	NULL
and	NULL
M9	NULL
probes	NULL
should	NULL
not	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
probe	NULL
MS	NULL
can	NULL
help	NULL
discriminate	NULL
between	NULL
E-box	NULL
binding	NULL
proteins	NULL
(	NULL
which	NULL
can	NULL
not	NULL
be	NULL
the	NULL
repressor	NULL
)	NULL
and	NULL
the	NULL
NIP	NULL
repressor	NULL
complex	NULL
itself	NULL
.	NULL

Only	NULL
complex	NULL
3	NULL
fulfills	NULL
the	NULL
above	NULL
requirements	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
complex	NULL
3	NULL
is	NULL
the	NULL
NIP	NULL
repressor	NULL
complex	NULL
.	NULL

We	NULL
have	NULL
designated	NULL
this	NULL
activity	NULL
NIP-C3	NULL
,	NULL
for	NULL
NIP-complex	NULL
3	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
,	NULL
which	NULL
also	NULL
directs	NULL
T	NULL
cell-specific	NULL
expres-sion	NULL
,	NULL
contains	NULL
a	NULL
repressor	NULL
site	NULL
,	NULL
NRE-A	NULL
,	NULL
which	NULL
binds	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
es	NULL
)	NULL
binding	NULL
to	NULL
the	NULL
NRE-A	NULL
and	NULL
NIP	NULL
sites	NULL
showed	NULL
them	NULL
to	NULL
have	NULL
different	NULL
mo-bilities	NULL
in	NULL
EMSA	NULL
.	NULL

Furthermore	NULL
,	NULL
NIP	NULL
oligonucleotides	NULL
did	NULL
not	NULL
compete	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
NRE-A	NULL
probe	NULL
;	NULL
nor	NULL
did	NULL
NRE-A	NULL
oligonucleotides	NULL
compete	NULL
NIP-C3	NULL
binding	NULL
to	NULL
its	NULL
cognate	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
IL-2	NULL
repressor	NULL
and	NULL
NIP-C3	NULL
are	NULL
distinct	NULL
from	NULL
each	NULL
other	NULL
.	NULL

NIP-C3	NULL
Can	NULL
Be	NULL
Detected	NULL
in	NULL
Different	NULL
Cell	NULL
Types	NULL
and	NULL
Organ-isms-To	NULL
further	NULL
characterize	NULL
NIP-C3	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
various	NULL
primate	NULL
and	NULL
murine	NULL
cell	NULL
lines	NULL
were	NULL
tested	NULL
with	NULL
the	NULL
same	NULL
set	NULL
of	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

NIP-C3	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
cases	NULL
.	NULL

An	NULL
equivalent	NULL
amount	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
already	NULL
shown	NULL
,	NULL
NIP-C3	NULL
is	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
gibbon	NULL
T	NULL
cell	NULL
line	NULL
MLA	NULL
144	NULL
.	NULL

The	NULL
prominent	NULL
complex	NULL
that	NULL
migrates	NULL
ahead	NULL
of	NULL
NIP-C3	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
a	NULL
breakdown	NULL
product	NULL
of	NULL
NIP-C3	NULL
since	NULL
it	NULL
binds	NULL
to	NULL
probe	NULL
M9	NULL
.	NULL

Its	NULL
significance	NULL
,	NULL
if	NULL
any	NULL
,	NULL
is	NULL
unknown	NULL
.	NULL

NIP-C3	NULL
is	NULL
also	NULL
detected	NULL
in	NULL
erythroleukemic	NULL
K562	NULL
cells	NULL
,	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
,	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
Raji	NULL
)	NULL
,	NULL
mouse	NULL
pre-B	NULL
cells	NULL
(	NULL
2M3	NULL
)	NULL
,	NULL
and	NULL
mouse	NULL
myotube	NULL
(	NULL
C2DM	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
NIP-C3	NULL
varies	NULL
from	NULL
cell	NULL
line	NULL
to	NULL
cell	NULL
line	NULL
,	NULL
NIP-C3	NULL
migration	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
same	NULL
in	NULL
all	NULL
preparations	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
faster	NULL
component	NULL
in	NULL
the	NULL
NIP-C3	NULL
doublet	NULL
in	NULL
mouse	NULL
pre-B	NULL
cells	NULL
.	NULL

This	NULL
component	NULL
may	NULL
have	NULL
arisen	NULL
from	NULL
proteolytic	NULL
degradation	NULL
or	NULL
may	NULL
represent	NULL
an	NULL
altered	NULL
form	NULL
of	NULL
NIP-C3	NULL
.	NULL

DISCUSSION	NULL
The	NULL
presence	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
IL-3	NULL
promoter	NULL
was	NULL
originally	NULL
recognized	NULL
when	NULL
a	NULL
truncated	NULL
IL-3	NULL
promoter	NULL
lacking	NULL
the	NULL
AP-1/Elf-1	NULL
sites	NULL
was	NULL
tested	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
12	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
localized	NULL
this	NULL
element	NULL
between	NULL
nt	NULL
-244	NULL
and	NULL
-270	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
and	NULL
showed	NULL
that	NULL
it	NULL
also	NULL
functions	NULL
as	NULL
a	NULL
repressor	NULL
in	NULL
primary	NULL
T	NULL
lymphocytes	NULL
(	NULL
23	NULL
)	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
Hela	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
repression	NULL
function	NULL
of	NULL
the	NULL
NIP	NULL
region	NULL
(	NULL
-267	NULL
to	NULL
-244	NULL
)	NULL
is	NULL
preserved	NULL
when	NULL
placed	NULL
in	NULL
a	NULL
different	NULL
location	NULL
within	NULL
the	NULL
IL-3	NULL
promoter	NULL
or	NULL
transferred	NULL
in	NULL
cis	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
repression	NULL
through	NULL
the	NULL
NIP	NULL
site	NULL
is	NULL
not	NULL
cell-restricted	NULL
and	NULL
may	NULL
play	NULL
a	NULL
more	NULL
general	NULL
role	NULL
than	NULL
the	NULL
one	NULL
involved	NULL
in	NULL
IL-3	NULL
regulation	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
24577	NULL
C	NULL
.P	NULL
P	NULL
is	NULL
SF	NULL
£	NULL
£	NULL
®	NULL
®	NULL
®	NULL
$	NULL
£	NULL
``	NULL
&	NULL
«	NULL
*	NULL
«	NULL
¢	NULL
.g	NULL
6	NULL
3	NULL
®	NULL
&	NULL
¥	NULL
o	NULL
ewan	NULL
|	NULL
<	NULL
-	NULL
USF	NULL
-	NULL
Supershift	NULL
wese	NULL
<	NULL
4Complex	NULL
20	NULL
»	NULL
f	NULL
l	NULL
L__j	NULL
NIP-5	NULL
'	NULL
Probe	NULL
L_	NULL
USF	NULL
Probe	NULL
NIP-5	NULL
'	NULL
USF	NULL
Probe	NULL
Probe	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Complex	NULL
2	NULL
is	NULL
related	NULL
to	NULL
or	NULL
identical	NULL
to	NULL
USF	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
were	NULL
tested	NULL
in	NULL
EMSA	NULL
with	NULL
a	NULL
NIP-5	NULL
'	NULL
probe	NULL
in	NULL
buffer	NULL
A	NULL
.	NULL

The	NULL
nuclear	NULL
extract	NULL
was	NULL
either	NULL
directly	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
first	NULL
Zane	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
an	NULL
antibody	NULL
raised	NULL
against	NULL
the	NULL
20	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
USF	NULL
(	NULL
Zane	NULL
eUSF-Ab	NULL
)	NULL
,	NULL
or	NULL
incubated	NULL
with	NULL
the	NULL
same	NULL
antibody	NULL
blocked	NULL
with	NULL
excess	NULL
peptide	NULL
against	NULL
which	NULL
the	NULL
antibody	NULL
was	NULL
raised	NULL
(	NULL
Zane	NULL
«	NULL
USF-Ab	NULL
+	NULL
peptide	NULL
)	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
the	NULL
same	NULL
experiment	NULL
was	NULL
performed	NULL
except	NULL
that	NULL
a	NULL
USF	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Experiments	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
were	NULL
run	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

As	NULL
apparent	NULL
from	NULL
the	NULL
intensity	NULL
corresponding	NULL
to	NULL
free	NULL
probe	NULL
,	NULL
exposure	NULL
time	NULL
for	NULL
panel	NULL
!	NULL

A	NULL
was	NULL
longer	NULL
than	NULL
for	NULL
panel	NULL
B	NULL
.	NULL

C	NULL
,	NULL
binding	NULL
of	NULL
purified	NULL
USF	NULL
(	NULL
from	NULL
HeLa	NULL
cells	NULL
)	NULL
to	NULL
NIP-5	NULL
'	NULL
and	NULL
USF	NULL
probes	NULL
.	NULL

The	NULL
two	NULL
reactions	NULL
were	NULL
run	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

The	NULL
lane	NULL
with	NULL
NIP-5	NULL
'	NULL
as	NULL
a	NULL
probe	NULL
was	NULL
exposed	NULL
longer	NULL
.	NULL

.°\§	NULL
’	NULL
Qe	NULL
‘	NULL
©	NULL
,	NULL
s	NULL
o	NULL
&	NULL
,	NULL
``	NULL
3°	NULL
33	NULL
3°	NULL
9°	NULL
¢	NULL
!	NULL

&	NULL
°	NULL
p	NULL
-	NULL
sous	NULL
were	NULL
o-	NULL
Gram	NULL
fraud	NULL
won	NULL
que	NULL
RB	NULL
-B	NULL
NIP	NULL
Functional	NULL
Consensus	NULL
:	NULL
-	NULL
CTEACNTNC	NULL
E-box	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

The	NULL
functional	NULL
consensus	NULL
for	NULL
NIP	NULL
repression	NULL
is	NULL
different	NULL
from	NULL
the	NULL
E-box	NULL
consensus	NULL
.	NULL

Reporter	NULL
gene	NULL
constructs	NULL
with	NULL
different	NULL
mutations	NULL
in	NULL
the	NULL
-267	NULL
IL-3	NULL
promoter	NULL
fragment	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
for	NULL
sequences	NULL
)	NULL
were	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Migration	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
derived	NULL
from	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
.	NULL

Plasmid	NULL
-173/1L3*	NULL
(	NULL
lane	NULL
labeled	NULL
NIP	NULL
minus	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
NIP	NULL
site	NULL
,	NULL
and	NULL
plasmid	NULL
-267/1L3*	NULL
(	NULL
lane	NULL
labeled	NULL
wild-type	NULL
)	NULL
containing	NULL
an	NULL
intact	NULL
NIP	NULL
element	NULL
served	NULL
as	NULL
controls	NULL
.	NULL

Equal	NULL
loading	NULL
for	NULL
RNA	NULL
was	NULL
achieved	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
prominent	NULL
151-nt	NULL
fragment	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

Results	NULL
from	NULL
the	NULL
eight	NULL
mutants	NULL
shown	NULL
here	NULL
and	NULL
three	NULL
additional	NULL
mutants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
define	NULL
the	NULL
consen-	NULL
sus	NULL
for	NULL
NIP	NULL
repressor	NULL
function	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

The	NULL
NIP	NULL
region	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
identify	NULL
proteins	NULL
that	NULL
might	NULL
mediate	NULL
its	NULL
repression	NULL
function	NULL
.	NULL

Using	NULL
various	NULL
assay	NULL
conditions	NULL
for	NULL
DNA	NULL
binding	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
three	NULL
specific	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
most	NULL
prominent	NULL
complex	NULL
is	NULL
complex	NULL
1	NULL
.	NULL

Partial	NULL
characterization	NULL
and	NULL
purification	NULL
of	NULL
complex	NULL
1	NULL
indicate	NULL
that	NULL
it	NULL
is	NULL
a	NULL
ubiquitous	NULL
protein	NULL
of	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
63	NULL
kDa	NULL
.	NULL

?	NULL

It	NULL
forms	NULL
on	NULL
the	NULL
3	NULL
'	NULL
half	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
and	NULL
is	NULL
dispensable	NULL
for	NULL
repression	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Its	NULL
role	NULL
in	NULL
IL-3	NULL
regulation	NULL
remains	NULL
unknown	NULL
.	NULL

A	NULL
complex	NULL
with	NULL
similar	NULL
proper	NULL
*	NULL
K.	NULL
Engeland	NULL
,	NULL
N.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
B.	NULL
Mathey-Prevot	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

ties	NULL
has	NULL
been	NULL
described	NULL
,	NULL
which	NULL
binds	NULL
a	NULL
site	NULL
in	NULL
the	NULL
stromelysin	NULL
gene	NULL
promoter	NULL
and	NULL
appears	NULL
to	NULL
mediate	NULL
phorbol	NULL
ester	NULL
activation	NULL
in	NULL
cooperation	NULL
with	NULL
a	NULL
nearby	NULL
AP-1	NULL
site	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
half	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
interacts	NULL
with	NULL
two	NULL
distinct	NULL
protein	NULL
complexes	NULL
to	NULL
form	NULL
complex	NULL
2	NULL
and	NULL
complex	NULL
3	NULL
.	NULL

Both	NULL
complexes	NULL
are	NULL
expressed	NULL
ubiquitously	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
appear	NULL
to	NULL
be	NULL
conserved	NULL
across	NULL
different	NULL
species	NULL
.	NULL

Since	NULL
a	NULL
consensus	NULL
sequence	NULL
for	NULL
an	NULL
E-box	NULL
binding	NULL
protein	NULL
is	NULL
present	NULL
in	NULL
the	NULL
5	NULL
half	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
either	NULL
of	NULL
the	NULL
two	NULL
complexes	NULL
might	NULL
be	NULL
a	NULL
member	NULL
of	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eleven	NULL
mutant	NULL
oligonucleotides	NULL
of	NULL
the	NULL
NIP-5	NULL
'	NULL
probe	NULL
were	NULL
tested	NULL
as	NULL
competitors	NULL
in	NULL
EMSAs	NULL
revealing	NULL
that	NULL
the	NULL
binding	NULL
specificity	NULL
of	NULL
complex	NULL
2	NULL
(	NULL
CACNTG	NULL
)	NULL
matched	NULL
the	NULL
general	NULL
consensus	NULL
sequence	NULL
of	NULL
an	NULL
E-box	NULL
site	NULL
(	NULL
CANNTG	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
complex	NULL
2	NULL
was	NULL
explored	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
ubiquitous	NULL
E-box	NULL
proteins	NULL
.	NULL

Complex	NULL
2	NULL
was	NULL
disrupted	NULL
by	NULL
an	NULL
antiserum	NULL
recognizing	NULL
the	NULL
general	NULL
transcriptional	NULL
activator	NULL
USF	NULL
.	NULL

Additional	NULL
experiments	NULL
established	NULL
that	NULL
complex	NULL
2	NULL
is	NULL
identical	NULL
or	NULL
closely	NULL
related	NULL
to	NULL
USF	NULL
.	NULL

Complex	NULL
2	NULL
can	NULL
not	NULL
be	NULL
the	NULL
NIP	NULL
repressor	NULL
,	NULL
however	NULL
,	NULL
since	NULL
its	NULL
DNA-binding	NULL
specificity	NULL
differs	NULL
from	NULL
the	NULL
functional	NULL
repressor	NULL
consensus	NULL
sequence	NULL
CTCACNTNC	NULL
.	NULL

Other	NULL
E-box	NULL
binding	NULL
proteins	NULL
are	NULL
also	NULL
unlikely	NULL
candidates	NULL
,	NULL
since	NULL
a	NULL
mutation	NULL
altering	NULL
the	NULL
invariant	NULL
G	NULL
in	NULL
the	NULL
NIP	NULL
E-box	NULL
core	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
repressor	NULL
function	NULL
.	NULL

Since	NULL
neither	NULL
complex	NULL
1	NULL
nor	NULL
complex	NULL
2	NULL
binding	NULL
correlated	NULL
with	NULL
repressor	NULL
activity	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
complex	NULL
3	NULL
,	NULL
the	NULL
only	NULL
remaining	NULL
candidate	NULL
for	NULL
this	NULL
function	NULL
.	NULL

The	NULL
use	NULL
of	NULL
different	NULL
informative	NULL
mutant	NULL
oligonucleotides	NULL
as	NULL
DNA	NULL
probes	NULL
in	NULL
EMSA	NULL
showed	NULL
that	NULL
,	NULL
among	NULL
the	NULL
three	NULL
complexes	NULL
that	NULL
form	NULL
on	NULL
the	NULL
NIP	NULL
region	NULL
,	NULL
only	NULL
complex	NULL
3	NULL
,	NULL
designated	NULL
NIP-C3	NULL
,	NULL
displayed	NULL
the	NULL
appropriate	NULL
specificity	NULL
for	NULL
being	NULL
the	NULL
repressor	NULL
.	NULL

NIP-C3	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
tissues	NULL
and	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Its	NULL
binding	NULL
in	NULL
vitro	NULL
is	NULL
exquisitely	NULL
sensitive	NULL
to	NULL
the	NULL
type	NULL
of	NULL
nonspecific	NULL
DNA	NULL
present	NULL
in	NULL
the	NULL
binding	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
24578	NULL
Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
B	NULL
Bo	NULL
,	NULL
s	NULL
$	NULL
A	NULL
<	NULL
&	NULL
yop	NULL
y	NULL
£5	NULL
3°	NULL
3°	NULL
£	NULL
,	NULL
3°	NULL
3°	NULL
3°	NULL
Different	NULL
Probes	NULL
Different	NULL
Probes	NULL
S	NULL
--	NULL
taman	NULL
msl	NULL
.	NULL

<	NULL
-USF	NULL
buat	NULL
<	NULL
-	NULL
NIP-C3	NULL
<	NULL
-	NULL
NIP-C3	NULL
Different	NULL
Probes	NULL
imams	NULL
USF	NULL
(	NULL
Complex	NULL
2	NULL
)	NULL
-	NULL
»	NULL
Hast	NULL
rae	NULL
Head	NULL
lad	NULL
bona	NULL
Jurkat	NULL
(	NULL
stim	NULL
.	NULL
)	NULL

MLA	NULL
144	NULL
NIP-C3	NULL
(	NULL
Complex	NULL
3	NULL
)	NULL
i	NULL
<	NULL
-USF	NULL
eed	NULL
%	NULL
eens	NULL
tunes	NULL
<	NULL
nrcs	NULL
@	NULL
«	NULL
-	NULL
NIP-C3	NULL
K	NULL
562	NULL
MEL	NULL
H.	NULL
“	NULL
<	NULL
-	NULL
NIP-C3	NULL
-	NULL
Cg	NULL
=_-	NULL
wt-	NULL
USF	NULL
boued	NULL
wee	NULL
:	NULL
:	NULL
|	NULL
NIP-C3	NULL
Raji	NULL
mouse	NULL
pre-B	NULL
Jurkat	NULL
(	NULL
unstim	NULL
.	NULL
)	NULL

wine	NULL
_	NULL
wite	NULL
was	NULL
<	NULL
-	NULL
NIP-C3	NULL
Myotube	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Binding	NULL
of	NULL
complex	NULL
3	NULL
correlates	NULL
with	NULL
repression	NULL
function	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
were	NULL
tested	NULL
in	NULL
EMSA	NULL
using	NULL
the	NULL
probes	NULL
shown	NULL
above	NULL
each	NULL
Zane	NULL
.	NULL

Sequences	NULL
for	NULL
the	NULL
various	NULL
probes	NULL
are	NULL
listed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

A	NULL
,	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
the	NULL
source	NULL
of	NULL
nuclear	NULL
extract	NULL
is	NULL
indicated	NULL
for	NULL
each	NULL
panel	NULL
.	NULL

Only	NULL
the	NULL
area	NULL
of	NULL
interest	NULL
is	NULL
shown	NULL
.	NULL

Migration	NULL
of	NULL
complex	NULL
2/USF	NULL
and	NULL
of	NULL
NIP-C3	NULL
is	NULL
indicated	NULL
for	NULL
each	NULL
panel	NULL
.	NULL

stim	NULL
.	NULL

,	NULL
stimulated	NULL
;	NULL
unsfim	NULL
.	NULL

,	NULL
unstimulated	NULL
.	NULL

reaction	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
NIP-C3	NULL
when	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
used	NULL
as	NULL
carrier	NULL
.	NULL

This	NULL
behavior	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
SEF1	NULL
,	NULL
which	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
8-crystallin	NULL
enhancer	NULL
and	NULL
was	NULL
subsequently	NULL
found	NULL
to	NULL
repress	NULL
E2-box-mediated	NULL
gene	NULL
activation	NULL
through	NULL
competition	NULL
of	NULL
binding	NULL
.	NULL

Although	NULL
NIP-C3	NULL
and	NULL
dEF1	NULL
share	NULL
similar	NULL
binding	NULL
specificities	NULL
,	NULL
they	NULL
differ	NULL
in	NULL
recognition	NULL
of	NULL
at	NULL
least	NULL
one	NULL
important	NULL
position	NULL
,	NULL
where	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
specific	NULL
nucleotide	NULL
inactivates	NULL
NIP	NULL
repressor	NULL
function	NULL
while	NULL
it	NULL
favors	NULL
8EF1	NULL
function	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
two	NULL
proteins	NULL
may	NULL
share	NULL
similar	NULL
mechanisms	NULL
of	NULL
repression	NULL
,	NULL
the	NULL
above	NULL
difference	NULL
strongly	NULL
argues	NULL
that	NULL
the	NULL
two	NULL
factors	NULL
are	NULL
different	NULL
.	NULL

There	NULL
is	NULL
accumulating	NULL
evidence	NULL
that	NULL
a	NULL
growing	NULL
number	NULL
of	NULL
proteins	NULL
function	NULL
by	NULL
displacing	NULL
helix-loop-helix	NULL
transcription	NULL
factors	NULL
from	NULL
their	NULL
cognate	NULL
E-box	NULL
sequences	NULL
.	NULL

Indeed	NULL
,	NULL
another	NULL
zinc	NULL
finger	NULL
protein	NULL
,	NULL
ZEB	NULL
,	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
able	NULL
to	NULL
silence	NULL
the	NULL
IgH	NULL
enhancer	NULL
by	NULL
displacing	NULL
the	NULL
E2A	NULL
complex	NULL
from	NULL
its	NULL
cognate	NULL
site	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Since	NULL
binding	NULL
sites	NULL
for	NULL
complex	NULL
2/USF	NULL
and	NULL
the	NULL
repressor	NULL
significantly	NULL
overlap	NULL
,	NULL
a	NULL
dynamic	NULL
equilibrium	NULL
of	NULL
occupancy	NULL
by	NULL
complex2/USF	NULL
and	NULL
NIP-C3	NULL
over	NULL
the	NULL
5°	NULL
portion	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
may	NULL
dictate	NULL
appropriate	NULL
IL-3	NULL
expression	NULL
in	NULL
an	NULL
analogous	NULL
manner	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Why	NULL
should	NULL
the	NULL
IL-3	NULL
promoter	NULL
contain	NULL
a	NULL
strong	NULL
repressor	NULL
element	NULL
?	NULL

IL-3	NULL
is	NULL
a	NULL
potent	NULL
growth	NULL
factor	NULL
,	NULL
which	NULL
plays	NULL
multiple	NULL
,	NULL
complementary	NULL
roles	NULL
in	NULL
normal	NULL
hematopoiesis	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Meticulous	NULL
control	NULL
of	NULL
its	NULL
production	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
prevent	NULL
unbridled	NULL
proliferation	NULL
of	NULL
progenitor	NULL
cells	NULL
and	NULL
to	NULL
meet	NULL
the	NULL
body	NULL
's	NULL
fluctuating	NULL
needs	NULL
for	NULL
differentiated	NULL
cells	NULL
.	NULL

IL-3	NULL
may	NULL
be	NULL
an	NULL
example	NULL
of	NULL
a	NULL
protein	NULL
that	NULL
is	NULL
so	NULL
deleterious	NULL
when	NULL
overproduced	NULL
that	NULL
blocking	NULL
its	NULL
expression	NULL
may	NULL
be	NULL
of	NULL
greater	NULL
importance	NULL
than	NULL
activating	NULL
its	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
proximal	NULL
portion	NULL
of	NULL
the	NULL
IL-3	NULL
promoter	NULL
activates	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
transcription	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
12	NULL
)	NULL
,	NULL
yet	NULL
IL-3	NULL
is	NULL
produced	NULL
only	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
NIP	NULL
repressor	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
clamp	NULL
that	NULL
normally	NULL
prevents	NULL
IL-3	NULL
transcription	NULL
in	NULL
all	NULL
cells	NULL
.	NULL

Its	NULL
effect	NULL
,	NULL
however	NULL
,	NULL
can	NULL
be	NULL
specifically	NULL
abrogated	NULL
when	NULL
the	NULL
upstream	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
sequences	NULL
engage	NULL
proteins	NULL
expressed	NULL
only	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Future	NULL
studies	NULL
must	NULL
be	NULL
aimed	NULL
at	NULL
understanding	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
factors	NULL
acting	NULL
at	NULL
the	NULL
AP-1	NULL
and	NULL
EIf-1	NULL
sites	NULL
relieve	NULL
NIP	NULL
repression	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
D.	NULL
G.	NULL
Nathan	NULL
for	NULL
intellectual	NULL
in-put	NULL
,	NULL
encouragement	NULL
,	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
David	NULL
Fisher	NULL
for	NULL
discussions	NULL
and	NULL
advice	NULL
regarding	NULL
USF	NULL
.	NULL

REFERENCES	NULL
.	NULL

Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
286-289	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Kamen	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
286	NULL
,	NULL
1229-1237	NULL
.	NULL

Yang	NULL
,	NULL
Y.-C.	NULL
,	NULL
Temple	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Chung	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Kovacic	NULL
,	NULL
S.	NULL
,	NULL
Witek-Giannotti	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Leary	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Kriz	NULL
,	NULL
R.	NULL
,	NULL
Donahue	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
3-10	NULL
4	NULL
.	NULL

Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Brown	NULL
,	NULL
N.	NULL
,	NULL
Otsu	NULL
,	NULL
K.	NULL
,	NULL
Abramson	NULL
,	NULL
J.	NULL
,	NULL
Saeland	NULL
,	NULL
S.	NULL
,	NULL
Caux	NULL
,	NULL
C.	NULL
,	NULL
De	NULL
Waal	NULL
Malefijt	NULL
,	NULL
R.	NULL
,	NULL
De	NULL
Vries	NULL
,	NULL
J.	NULL
,	NULL
Meyerson	NULL
,	NULL
P.	NULL
,	NULL
Yokota	NULL
,	NULL
K.	NULL
,	NULL
Gemmel	NULL
,	NULL
L.	NULL
,	NULL
Rennick	NULL
,	NULL
D.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.-L.	NULL
,	NULL
and	NULL
Yokota	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
2288-2296	NULL
5	NULL
.	NULL

Niemeyer	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Sieff	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
945-951	NULL
6	NULL
.	NULL

Wimperis	NULL
,	NULL
J	NULL
.	NULL

Z.	NULL
,	NULL
Niemeyer	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Sieff	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Arceci	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1525-1530	NULL
7	NULL
.	NULL

Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Milton	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Lopez	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Vadas	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1195-1202	NULL
8	NULL
.	NULL

Shoemaker	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Hromas	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kaushansky	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9650-9654	NULL
9	NULL
.	NULL

Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Murphy	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Kreissman	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5046-5050	NULL
10	NULL
.	NULL

Davies	NULL
,	NULL
K.	NULL
,	NULL
TePas	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
928-934	NULL
11	NULL
.	NULL

Cameron	NULL
,	NULL
S.	NULL
,	NULL
Taylor	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
TePas	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Mathey-Prevot	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2851-2859	NULL
12	NULL
.	NULL

Gottechalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Giannola	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Emerson	NULL
,	NULL
S.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1681-1692	NULL
13	NULL
.	NULL

Koyano-Nakagawa	NULL
,	NULL
N.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Baldwin	NULL
,	NULL
D.	NULL
,	NULL
Arai	NULL
,	NULL
K..	NULL
,	NULL
and	NULL
Yokota	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5099-5107	NULL
14	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Moolten	NULL
,	NULL
D.	NULL
,	NULL
Burlein	NULL
,	NULL
J.	NULL
,	NULL
Romano	NULL
,	NULL
J.	NULL
,	NULL
Bhaerman	NULL
,	NULL
R.	NULL
,	NULL
Godillot	NULL
,	NULL
A.	NULL
,	NULL
Mellon	NULL
,	NULL
M.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
and	NULL
Kant	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
254	NULL
,	NULL
1791-1794	NULL
15	NULL
.	NULL

Church	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Gilbert	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Tonegawa	NULL
,	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
818	NULL
,	NULL
co	NULL
Ro	NULL
|A	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
NIP	NULL
Repressor	NULL
Site	NULL
798-801	NULL
Faisst	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Meyer	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
3-26	NULL
Kawamaki	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Huff	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Buckley	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Dungworth	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Snyder	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Gilden	NULL
,	NULL
R.	NULL
V.	NULL
(	NULL
1972	NULL
)	NULL
Nature	NULL
285	NULL
,	NULL
170-171	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
in	NULL
Lymphokines	NULL
,	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
pp	NULL
.	NULL

375-391	NULL
(	NULL
Schrader	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.-C.	NULL
,	NULL
eds	NULL
)	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebowitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
Faller	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
2499	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
Voronova	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1156-1160	NULL
Gregor	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Sawadogo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1730-1740	NULL
23	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

24579	NULL
.	NULL

Wolin	NULL
,	NULL
M.	NULL
,	NULL
Kornuce	NULL
,	NULL
M.	NULL
,	NULL
Hong	NULL
,	NULL
C.	NULL
,	NULL
Shin	NULL
,	NULL
S.-K.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
,	NULL
Lau	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Nimer	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
1905-1911	NULL
Sirum-Conally	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Brinckerhoff	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
335-341	NULL
Sekido	NULL
,	NULL
R.	NULL
,	NULL
Murai	NULL
,	NULL
K.	NULL
,	NULL
Funahashi	NULL
,	NULL
J.-L.	NULL
,	NULL
Kamachi	NULL
,	NULL
Y.	NULL
,	NULL
Fujisawa-Sebara	NULL
,	NULL
A.	NULL
,	NULL
Nabeshima	NULL
,	NULL
Y.-L.	NULL
,	NULL
and	NULL
Kondoh	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5692-5700	NULL
Sakamoto	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Fraser	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Lee	NULL
,	NULL
H.-J	NULL
.	NULL

J.	NULL
,	NULL
Lehman	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5975-5985	NULL
Genetta	NULL
,	NULL
T.	NULL
,	NULL
Ruezinsky	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6153-6163	NULL
Nimer	NULL
,	NULL
8	NULL
.	NULL

D.	NULL
,	NULL
Morita	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Martis	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Wachsman	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1979-1984	NULL
Sawadogo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
165-175	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Multiple	NULL
Proteins	NULL
Interact	NULL
with	NULL
the	NULL
Nuclear	NULL
Inhibitory	NULL
Protein	NULL
Repressor	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
Interleukin-3	NULL
Promoter	NULL
Kurt	NULL
Engeland	NULL
,	NULL
Nancy	NULL
C.	NULL
Andrews	NULL
and	NULL
Bernard	NULL
Mathey-Prevot	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:24572-24579.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.41.24572	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/41/24572	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
29	NULL
references	NULL
,	NULL
17	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

